Back to top

Noble Financial Keeps Their Buy Rating on Zomedica (ZOMDF)

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Zomedica (ZOMDF – Research Report), with a price target ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Zomedica Corp. (ZOMDF)